Maxcyte (MXCT) Market Capitalization (2021 - 2026)

Maxcyte (MXCT) has reported Market Capitalization for 6 consecutive years, with $130.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization fell 43.82% year-over-year to $130.5 million in Q2 2026; TTM through Jun 2026 was $130.5 million, a 43.82% decrease from a year earlier, with the FY2025 full-year figure at $165.5 million, down 62.36% from the prior year.
• Market Capitalization was $130.5 million for Q2 2026 at Maxcyte, up from $75.3 million in the prior quarter.
• Over five years, Market Capitalization peaked at $709.6 million in Q1 2022 and troughed at $75.3 million in Q1 2026.
• A 5-year average of $387.0 million and a median of $424.2 million in 2024 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization gained 26.79% in 2024 and slumped 74.07% in 2026, its largest moves.
• Over 5 years, Market Capitalization stood at $559.1 million in 2022, then decreased by 12.6% to $488.6 million in 2023, then dropped by 10.0% to $439.8 million in 2024, then plunged by 62.36% to $165.5 million in 2025, then declined by 21.13% to $130.5 million in 2026.
• The last three Market Capitalization figures came in at $130.5 million (Q2 2026), $75.3 million (Q1 2026), and $165.5 million (Q4 2025), per Business Quant data.